- Home
- SAGE vs GLDD Comparison
SAGE vs GLDD Comparison
Compare SAGE & GLDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- GLDD
- Stock Information
- Founded
- SAGE 2010
- GLDD 1890
- Country
- SAGE United States
- GLDD United States
- Employees
- SAGE N/A
- GLDD N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- GLDD Military/Government/Technical
- Sector
- SAGE Health Care
- GLDD Industrials
- Exchange
- SAGE Nasdaq
- GLDD Nasdaq
- Market Cap
- SAGE 474.6M
- GLDD 516.1M
- IPO Year
- SAGE 2014
- GLDD 2006
- Fundamental
- Price
- SAGE $7.37
- GLDD $8.57
- Analyst Decision
- SAGE Hold
- GLDD Buy
- Analyst Count
- SAGE 19
- GLDD 1
- Target Price
- SAGE $9.88
- GLDD $14.00
- AVG Volume (30 Days)
- SAGE 1.2M
- GLDD 427.4K
- Earning Date
- SAGE 04-24-2025
- GLDD 05-06-2025
- Dividend Yield
- SAGE N/A
- GLDD N/A
- EPS Growth
- SAGE N/A
- GLDD 301.51
- EPS
- SAGE N/A
- GLDD 0.84
- Revenue
- SAGE $41,243,000.00
- GLDD $762,693,000.00
- Revenue This Year
- SAGE $100.39
- GLDD $3.81
- Revenue Next Year
- SAGE $70.86
- GLDD $11.69
- P/E Ratio
- SAGE N/A
- GLDD $10.20
- Revenue Growth
- SAGE N/A
- GLDD 29.35
- 52 Week Low
- SAGE $4.62
- GLDD $6.55
- 52 Week High
- SAGE $17.51
- GLDD $12.89
- Technical
- Relative Strength Index (RSI)
- SAGE 40.58
- GLDD 43.45
- Support Level
- SAGE $7.99
- GLDD $8.51
- Resistance Level
- SAGE $7.97
- GLDD $9.10
- Average True Range (ATR)
- SAGE 0.31
- GLDD 0.29
- MACD
- SAGE -0.10
- GLDD 0.06
- Stochastic Oscillator
- SAGE 1.37
- GLDD 8.51
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About GLDD Great Lakes Dredge & Dock Corporation
Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.